HANSA MEDICAL AB ORD news, videos and press releases - Page 6
For more news please use our advanced search feature.
HANSA MEDICAL AB ORD - More news...
HANSA MEDICAL AB ORD - More news...
- Hansa Biopharma Announces Upcoming Presentations at the 2019 American Transplant Congress
- Hansa Biopharma Interim Report January-March 2019
- Notice to Annual General Meeting in Hansa Biopharma AB (publ)
- Hansa Biopharma Receives Ethics and Regulatory Clearance to Start Phase 2 Study of Imlifidase in Guillain Barré Syndrome
- Hansa Biopharma Divests its Equity Holding in Genovis
- Hansa Biopharma Publishes the Annual Report for 2018
- Hansa Biopharma Receives Ethics and Regulatory Clearance to Start Phase 2 Study of Imlifidase in Acute Antibody Mediated Rejection in Kidney Transplantation
- Hansa Biopharma Announces Selection of NiceR Lead Candidate
- Hansa Biopharma to Present at the Cowen 39th Annual Health Care Conference
- Hansa Biopharma Announces European Medicines Agency Accepts Marketing Authorization Application for IDEFIRIX™ (imlifidase)
- Hansa Biopharma Appoints Donato Spota as New Chief Financial Officer
- Hansa Medical Announces Appointment of Anne Säfström Lanner as Vice President, Global Human Resources
- Hansa Medical AB Provides Regulatory Update for Imlifidase in Kidney Transplantation
- Hansa Medical AB to Change Name to Hansa Biopharma AB
- Bulletin from the Extraordinary General Meeting of Hansa Medical AB (publ)
- Hansa Medical AB to Present at the Evercore ISI HealthConX Conference
- Hansa Medical to Present at the LD Micro Conference in Bel Air, California on December 2, 2015
